Opinion: After We March

How to become—and stay—involved in science policy

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, KRASSOTKINGiven instances in which the current administration has opposed facts—scientific or otherwise—and ongoing assaults on science, next month’s March for Science is a worthy first step toward getting those who care about research and American innovation engaged and ready to act. However, what’s most crucial will be what happens after the event.

Going forward, we must continue to find tangible ways to push for science’s inclusion in the policymaking process. There’s no single prescription to stay involved, so I’ll outline a few suggestions here and encourage readers get creative.

As a former congressional staffer, I know that concrete efforts, such as making the rounds on Capitol Hill in person to meet with representatives, really matter. If you can, take a few days to visit Senate and House offices to outline why the issues most important to you depend upon incorporating the best available science into legislation. When you meet with staffers, it’s vital that you don’t lose their attention by talking about p-values and statistics. Instead, remember to make clear arguments related to the economy, national security, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Sheril Kirshenbaum

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide